Stefanie Jones is a prominent figure in the realm of harm reduction advocacy, particularly within the context of nightlife, festivals, and events. As a self-employed freelance consultant, she leverages her extensive 16-year background with the Drug Policy Alliance (DPA) to drive progressive initiatives that promote...
Stefanie Jones is a prominent figure in the realm of harm reduction advocacy, particularly within the context of nightlife, festivals, and events. As a self-employed freelance consultant, she leverages her extensive 16-year background with the Drug Policy Alliance (DPA) to drive progressive initiatives that promote safer drug use and comprehensive drug education. Stefanie's current role involves collaborating with a diverse array of clients, including Fluence, the Drug Policy Alliance, and the Multidisciplinary Association for Psychedelic Studies (MAPS), where she develops and implements innovative strategies aimed at reshaping drug policies and enhancing public health outcomes.
Her expertise in communications planning and community outreach is pivotal in her efforts to foster understanding and acceptance of harm reduction practices. Stefanie excels in crafting compelling narratives that resonate with various stakeholders, ensuring that critical messages about drug safety and responsible use are effectively communicated. Her skills in fundraising and donor recognition have been instrumental in securing vital resources for programs that prioritize education and support over punitive measures.
Key projects Stefanie has spearheaded include the development of educational materials for event organizers, training sessions for staff on harm reduction practices, and community workshops that empower individuals to make informed choices regarding substance use. Through meticulous program evaluation and event management, she has successfully enhanced the impact of harm reduction initiatives, making them more accessible and effective. By harnessing the power of social media and press releases, Stefanie continues to amplify the conversation around drug policy reform, positioning herself as a leading advocate for change in the field.
